Caricamento...

Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors

Recently, there is considerable interest in the field of anti-HIV therapy to identify and develop chromatin-modifying histone deacetylase (HDAC) inhibitors that can effectively reactivate latent HIV in patients. The hope is that this would help eliminate cells harboring latent HIV and achieve an eve...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sahu, Gautam K, Cloyd, Miles W
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2011
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3168425/
https://ncbi.nlm.nih.gov/pubmed/21838863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-8-400
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !